Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2003
06/18/2003CN1424082A Asthma relieving paste for child
06/18/2003CN1424070A Plaster
06/18/2003CN1424064A Healthy medicinal spirit for tonifying kidney and strengthening Yang
06/18/2003CN1424054A Bacterial Chinese medical preparation and preparing method thereof
06/18/2003CN1424051A Lyophilized scorpion venoms powder injection
06/18/2003CN1424050A Capsules of rana amurensis ovary
06/18/2003CN1424042A Crataegus leaves flavone tablets and their preparing method
06/18/2003CN1424041A Kakonein preparations and their production
06/18/2003CN1424038A Preparation process for minoxidil spraying agent for treating bald and phalacrosis
06/18/2003CN1424036A Powder-injections of cyclonorfloxacin and its salts and their preparation
06/18/2003CN1424035A Lyophilized composition of nimodipine
06/18/2003CN1424024A External used paste for orthopedic diseases
06/18/2003CN1424020A Sun screener containing dibenzoyl methane derivative and amino substituted 2-hydroxy benzophenone derivative
06/18/2003CN1111425C Plaster for treating hyperosteogeny
06/18/2003CN1111416C Insomnic plaster
06/18/2003CN1111413C Anion exchange resin-containing tablets
06/18/2003CN1111412C Thrombus clearing soft capsule and preparation technology thereof
06/18/2003CN1111411C Antibacterial clindamycin phosphate powder injection and its preparing process
06/18/2003CN1111404C Controlled release oxybutynin formulation
06/18/2003CN1111402C Tramadol multiple unit formulations
06/17/2003US6579953 Graft polymers; improved flowability, greater hardness and less friability
06/17/2003US6579901 Pharmaceutical compositions and methods for treating immune-response associated diseases of the surface and the anterior segment of the eye
06/17/2003US6579895 Orally administration to provide a blood plasma concentration profile of celecoxib of at least about 250 mg/ml in not more than about 30 minutes
06/17/2003US6579891 Metal ion chelating agent such as picolinic acid or derivatives; zinc finger protein in a canine lymphoma cell
06/17/2003US6579865 For use in transdermally and topically applied drug delivery
06/17/2003US6579853 For inhibiting apoptosis or apoptosis-like cell death
06/17/2003US6579536 Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient
06/17/2003US6579535 Chewable tablet comprising a compressed agglomerate of a sugar alcohol, a high intensity sweetener, and water soluble binder; made using fluidized bed process
06/17/2003US6579534 Mixture of soy protein and isoflavone
06/17/2003US6579533 Bioabsorbable drug delivery system for local treatment and prevention of infections
06/17/2003US6579530 Cosmetic powder pencil or powder chalk
06/17/2003US6579529 Emulsifier-free finely disperse systems of the oil-in-water and water-in-oil type
06/17/2003US6579519 For therapy of eye infections such as conjunctivitis, blepharitis, keratitis sicca etc and to provide intraocular treatment through the cornea for diseases such as glaucoma or uveitis
06/17/2003US6579512 Topical steroid spray
06/17/2003US6579280 Generic multi-step therapeutic treatment protocol
06/17/2003US6579267 Pivoting joint infusion assembly
06/17/2003US6578607 Article comprising a diffuser with flow control features
06/17/2003CA2290973C Encapsulated solution dosage forms of sertraline
06/17/2003CA2284663C Rapidly dissolving robust dosage form
06/17/2003CA2232410C Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines
06/17/2003CA2228472C Tablets containing anion exchange resin
06/17/2003CA2183472C Liquid paraffin oil and lactulose-based hypocaloric laxative jelly and method for its preparation
06/17/2003CA2115504C Process for the stabilization of amphiphilic lipid(s)-containing vesicles and topical application composition containing said stabilized vesicles
06/17/2003CA2094030C A method for drug formulation and a pharmaceutical composition
06/17/2003CA2088163C Liposomes that provide thymic dependent help to weak vaccine antigens
06/17/2003CA2072249C Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
06/12/2003WO2003048666A1 Process for co-spray drying liquid herbal extracts with dry silicified mcc
06/12/2003WO2003048298A2 Nanoparticles containing polymeric nucleic acid homologs, pharmaceutical compositions and articles of manufacture containing same and methods of use thereof
06/12/2003WO2003048217A1 Process for production of water-soluble (meth)acrylic polymers, water-soluble (meth)acrylic polymers, and use thereof
06/12/2003WO2003048201A1 Antimicrobial bolisin peptides
06/12/2003WO2003048192A1 Novel peptides and medicinal uses thereof
06/12/2003WO2003047647A1 Method for forming matrices of hardened material
06/12/2003WO2003047643A1 Controlled release therapeutic wound dressings
06/12/2003WO2003047637A1 Sterilizing tunnel for pharmaceutical containers
06/12/2003WO2003047633A2 Treatment of angiogenesis disorders using targeted nanoparticles
06/12/2003WO2003047630A2 Method for oxygen treatment of unsaturated carbon compounds, novel epoxy-structured material obtained by the method, apparatus for carrying out the method and a therapeutic composition using the material
06/12/2003WO2003047629A2 Treatment of diseases via the skin
06/12/2003WO2003047609A1 A topical anti-itch formulation and a process for the preparation thereof
06/12/2003WO2003047605A1 Products of natural substance of organic iodine content
06/12/2003WO2003047595A1 Pharmaceutical compositions comprising active vitamin d compounds
06/12/2003WO2003047590A1 Antibiotic formulation and a method of making this formulation
06/12/2003WO2003047589A1 Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission
06/12/2003WO2003047587A1 Platinum derivative pharmaceutical formulations
06/12/2003WO2003047580A1 Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith
06/12/2003WO2003047566A1 Use of coumarin or its hydroxy derivative for the treatment of medium or severe vascular and/or lymphatic edema
06/12/2003WO2003047557A2 Device and patch for controlling the release of vanillin
06/12/2003WO2003047556A1 Transdermal therapeutic system provided with improved long-term carrying comfort
06/12/2003WO2003047555A1 Transdermal therapeutic systems containing steroid hormones and propylene glycol monocaprylate
06/12/2003WO2003047554A1 Transdermal drug delivery system of strychnine, brucine, securinine and their salts
06/12/2003WO2003047553A1 Synthesis of small particles
06/12/2003WO2003047552A2 Pharmaceutical composition comprising a 5ht1 receptor agonist
06/12/2003WO2003047551A1 Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose
06/12/2003WO2003047550A1 Aqueous base liquid pharmaceutical compositions in suspension form for the oral administration of ibuprofen
06/12/2003WO2003047549A2 Post-coated liposome/lipoplex for targeted drug/gene delivery and lipid linked to a delivery, targeting or stabilising moiety
06/12/2003WO2003047548A1 Pharmaceutical compositions in the form of gel or solution based on dihydrotestosterone, preparation method and uses thereof
06/12/2003WO2003047546A2 Agent for treating excess weight in association with other indications
06/12/2003WO2003047537A1 Antimicrobial composition comprising soy oil, rice bran oil and jojoba oil
06/12/2003WO2003047529A2 Extended release pharmaceutical tablet of metformin
06/12/2003WO2003047522A2 Composition and method for decreasing upper respiratory airway resistance
06/12/2003WO2003047521A2 Composition and method for treatment of otitis media
06/12/2003WO2003047519A2 'compressed annular tablet with molded triturate tablet for oral and intraoral'
06/12/2003WO2003047513A2 Method for treating ocular hypertension
06/12/2003WO2003047503A2 Delivery of medicaments to the nail
06/12/2003WO2003047502A1 Taste masked aqueous liquid pharmaceutical composition
06/12/2003WO2003047499A2 Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting
06/12/2003WO2003047497A1 Isotretinoin nanoparticulate compositions
06/12/2003WO2003047494A2 Reverse micelle compositions and uses thereof
06/12/2003WO2003047493A2 Stabilized reverse micelle compositions and uses thereof
06/12/2003WO2003047367A1 Solid and stable creatine/citric acid composition(s) and compositions containing carbohydrate(s) or hydrates thereof, method for the production and use thereof
06/12/2003WO2002000192A8 Embolization using carbon coated particles
06/12/2003US20030109856 Implantable vascular access device
06/12/2003US20030109819 Adhesive preparations
06/12/2003US20030109699 Biopolymers; gene therapy, medical diagnosis
06/12/2003US20030109647 Biodegradable polyhydric alcohol esters
06/12/2003US20030109639 Formulations of active components in the form of a solid dispersion
06/12/2003US20030109587 Gelling composition
06/12/2003US20030109577 Pharmaceutical composition containing citalopram
06/12/2003US20030109575 Emulsion of tocopherol incorporating a co-solvent and, stabilized by biocompatible surfactants, as a vehicle or carrier for therapeutic drugs, which is substantially ethanol free and which can be administered to animals or humans by
06/12/2003US20030109557 Calcium channel blockers such as amlodipine in the treatment of renal disease in normotensive animals. Also described are new unit doses of amlodipine suitable for the treatment of renal disease in normotensive cats.
06/12/2003US20030109515 Pharmaceutical formulation of a platinum derivative
1 ... 2129 2130 2131 2132 2133 2134 2135 2136 2137 2138 2139 2140 2141 2142 2143 2144 2145 2146 2147 2148 2149 ... 2991